No accord for the ACCORD-Lipid trial results
نویسندگان
چکیده
منابع مشابه
ACCORD Glycemia Results Continue to Puzzle
“I f I had a world of my own, everything would be nonsense. Nothing would be what it is, because everything would be what it isn’t. And contrary wise, what is, it wouldn’t be. And what it wouldn’t be, it would.” This quote by Alice from the Disney film version of Alice in Wonderland by Lewis Carroll may make sense in the world she experiences. In our world, Alice’s wish is usually not fulfilled...
متن کاملEffect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial
OBJECTIVE The Action to Control Cardiovascular Risk in Diabetes lipid study (ACCORD Lipid), which compared the effects of simvastatin plus fenofibrate (FENO-S) versus simvastatin plus placebo (PL-S) on cardiovascular disease outcomes, measured only fasting triglyceride (TG) levels. We examined the effects of FENO-S on postprandial (PP) lipid and lipoprotein levels in a subgroup of ACCORD Lipid ...
متن کاملThe ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial
A therosclerotic cardiovascular disease is increased severalfold in most patients with type 2 diabetes, particularly patients who are older and have other risk factors (1,2). These associated risk factors include hypertension, obesity, and dyslipidemia. Diabetic dyslipidemia, which has also been called atherogenic dyslipidemia (a term that describes the lipid abnormalities in people with insuli...
متن کاملACCORD Solutions for Flexible Working
Introduction In the last ten years the new, very promising, market of multimedia services has been attracting more and more computing, entertainment and communication industries. The incredible rate of growth which characterises the demand for multimedia service is driving the R&D sector towards the definition and implementation of telecommunication systems able to guarantee efficient and simul...
متن کاملInsulin Dose and Cardiovascular Mortality in the ACCORD Trial
OBJECTIVE In the ACCORD trial, intensive treatment of patients with type 2 diabetes and high cardiovascular (CV) risk was associated with higher all-cause and CV mortality. Post hoc analyses have failed to implicate rapid reduction of glucose, hypoglycemia, or specific drugs as the causes of this finding. We hypothesized that exposure to injected insulin was quantitatively associated with incre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Therapeutic Advances in Endocrinology and Metabolism
سال: 2010
ISSN: 2042-0188,2042-0196
DOI: 10.1177/2042018810376023